Stay healthy everybody.
Quite honestly, I’m insensitive to our share price volatility. This has been a long run for the company and it’s shareholders. The company is on the cusp, and truth be told there really is no meaningful competition. Anavex is very close.
The market is a sad commentary on the US financial system. The market reaction is not normal. There is no technical, no fundamental or no other valid reason for such a sharp decline. This drop is an orchestrated effort on the heels of CV-19 to change the US political landscape.
I ask those I know and trust if they have sold into the drop. Not one person has answered yes. I think that opinion is universal for most of retail. So I ask who are the “investors” pulling the strings?
Anyhow, I see little to no correlation to the overall market vs Anavex. Emerging biotechs move on clinical trial results, M&A / partnerships and regulatory approval.
IMO, those pulling the strings on the Anavex share price know that further drops will yield little shares and likely a deficit. The company has clearly been discovered. IMO, further drops will yield increased shares locked up for safe keeping.
IMO, there are so many dots, so many signals and so much due diligence that those who are here know what’s likely to happen in a few short months.
While nothing is a given, except the hoarding of toilet paper (my guess is we don’t see too many rolls in trees this year), the opportunity before us and presented by Anavex is unbelievable.
Easy to get frustrated with what is happening in the Market and with Anavex.
Keep the faith.
Patience
AI
Market Data 
Markets 
